RGT 3.64% 28.5¢ argent biopharma limited

Ann: MGC Research- Effectiveness of Cannabinoids on Brain Cancers, page-56

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 198 Posts.
    lightbulb Created with Sketch. 83
    Their pharma products have only hit the market in Q4 of FY19... What track record of them selling these products are you referring to?

    You do realise our products are only accessed through specialist access, so patients would need to get prescriptions directly from a relevant doctor. And if you read the announcement - "Mexacare provides the sales, marketing and logistics for diagnostic devices and complementary medicalproducts to pharmacies, allied health practitioners, labs, hospitals and doctors." To paraphrase, they will handle the logistic of getting the product to the consumer and provide services not just to pharmacies, but to doctors directly.

    Mexacare also has KPIs as part of the agreements - number of doctors briefed,quantity of product to be ordered, number of prescriptions issued and processed. So your comments around customers having to travel over "50kms" to access the our products is not relevant and unsubstantiated.
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
(20min delay)
Last
28.5¢
Change
0.010(3.64%)
Mkt cap ! $15.46M
Open High Low Value Volume
26.0¢ 28.5¢ 26.0¢ $264 932

Buyers (Bids)

No. Vol. Price($)
1 6148 28.5¢
 

Sellers (Offers)

Price($) Vol. No.
29.0¢ 1501 1
View Market Depth
Last trade - 14.18pm 15/11/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.